4.4 Article

Role of high-sensitivity C-reactive protein in patients with sarcoma

Related references

Note: Only part of the references are listed.
Article Oncology

Associations of body mass index and weight change with circulating levels of high-sensitivity C-reactive protein, proinflammatory cytokines, and adiponectin among breast cancer survivors

Hyun Jeong Cho et al.

Summary: This study examined the associations between body mass index (BMI) and weight change with inflammatory markers in breast cancer survivors. The results showed that a high BMI at diagnosis and current BMI with a greater degree were associated with unfavorable levels of inflammatory markers. Additionally, weight loss since diagnosis was inversely associated with these markers.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients

Ninna Aggerholm-Pedersen et al.

Summary: About 40 percent of patients with primary sarcoma experience relapse after treatment, leading to a low survival rate. Previous studies have failed to improve survival through adjuvant chemotherapy. This study provides a prognostic profile for sarcoma patients, identifying those who may not require additional treatment and those who would benefit from adjuvant treatment. The study also highlights the importance of the innate immune system in the prognosis of sarcoma patients.

CANCERS (2023)

Review Cell Biology

Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Tahmineh Kandelouei et al.

Summary: This meta-analysis study demonstrated the efficacy of statins in reducing CRP and hs-CRP levels in patients with various cardiovascular diseases.

MEDIATORS OF INFLAMMATION (2022)

Article Oncology

C-Reactive Protein Is an Indicator of the Immunosuppressive Microenvironment Fostered by Myeloid Cells in Hepatocellular Carcinoma

Yongchun Wang et al.

Summary: This study found that serum C-reactive protein (CRP) levels in patients with hepatocellular carcinoma (HCC) are correlated with liver functions and tumor stages. Patients with elevated serum CRP levels have higher densities of tumor-associated macrophages and tumor-associated neutrophils at the tumor site. In addition, CRP expression is associated with the expression of myeloid cell infiltration-related genes in HCC tumors. The combination of serum CRP with macrophages and neutrophils in the tumor microenvironment could be a powerful criterion for predicting patient prognoses.

FRONTIERS IN ONCOLOGY (2022)

Article Public, Environmental & Occupational Health

The Association of Serum High-Sensitivity C-Reactive Protein Level With the Risk of Site-Specific Cancer Mortality: The Health Examinees (HEXA) Study Cohort

Sang-Ah Lee et al.

Summary: This study examined the association between high-sensitivity C-reactive protein (hsCRP) level and cancer mortality in South Koreans. The results showed a dose-response association between hsCRP and overall cancer mortality in men, but not in women after excluding deaths occurring in the first 1 or 2 years of follow-up. Elevated hsCRP levels increased the risks of lung, liver, and gastric cancer mortality in men.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2022)

Review Oncology

Role of Tumor-Associated Macrophages in Sarcomas

Tomohiro Fujiwara et al.

Summary: Recent studies have highlighted the pro-tumoral role of TAMs in sarcomas, and drugs targeting TAMs may represent a novel therapeutic approach for bone and soft-tissue sarcomas. Promising results from clinical trials of TAM-targeted therapies warrant further investigation into their potential benefits for sarcoma patients.

CANCERS (2021)

Review Oncology

Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis

Michael Saerens et al.

Summary: The study evaluates the activity of ICPIs in the treatment of soft-tissue sarcomas (STS), revealing significant differences in their performance based on histologic subtype, disease setting, and combination treatment strategy. ICPIs showed high clinical activity in classic Kaposi sarcoma, alveolar soft part sarcoma, and undifferentiated pleomorphic sarcoma subtypes.

EUROPEAN JOURNAL OF CANCER (2021)

Article Oncology

C reactive protein impairs adaptive immunity in immune cells of patients with melanoma

Tatsuya Yoshida et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Oncology

Serum Biomarkers as Prognostic Factors for Metastatic Sarcoma

N. Aggerholm-Pedersen et al.

CLINICAL ONCOLOGY (2019)

Article Mathematical & Computational Biology

Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach

Ilker Unal

COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2017)

Article Oncology

The Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma

Ninna Aggerholm-Pedersen et al.

TRANSLATIONAL ONCOLOGY (2016)

Review Pharmacology & Pharmacy

Inflammation and cancer: How hot is the link?

Bharat B. Aggarwal et al.

BIOCHEMICAL PHARMACOLOGY (2006)

Review Multidisciplinary Sciences

Inflammation and cancer

LM Coussens et al.

NATURE (2002)

Article Medicine, General & Internal

Function of C-reactive protein

TW Du Clos

ANNALS OF MEDICINE (2000)